Explore how batch variability impacts bioequivalence standards. Learn why the 80-125% rule may be flawed and how new Between-Batch methods improve generic drug safety.
Dec, 27 2025
Jan, 18 2026
Jan, 15 2026
Apr, 25 2025
Jun, 4 2025